122 results
8-K
EX-10.1
BLPH
Bellerophon Therapeutics, Inc.
30 Jan 24
Entry into a Material Definitive Agreement
9:29am
. Tax Liability. Subscriber has reviewed with Subscriber’s own tax advisors the federal, state, local and foreign tax consequences of this investment … ) shall be responsible for Subscriber’s own tax liability that may arise as a result of this investment or the transactions contemplated by this Agreement
8-K
EX-2.1
f7cy6
13 Oct 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:45am
8-K
EX-10.1
m0z3wrw1c q9w1t2eul
9 Jun 23
Departure of Directors or Certain Officers
4:05pm
424B5
jaro0yidvy 2tau
31 May 23
Prospectus supplement for primary offering
4:40pm
8-K
EX-99.1
yp8ael8zjar8pn343obm
15 May 23
Bellerophon Provides Clinical Program Update and Reports First Quarter 2023 Financial Results
4:54pm